FDA Inspection 1264014 — Shandong Ruiying Pioneer Pharmaceutical Co., Ltd
The FDA completed an inspection of Shandong Ruiying Pioneer Pharmaceutical Co., Ltd on March 7, 2025 in Heze. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 7, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Heze (China)